仅供临床科研使用
QP-Prostate® 了解更多
销售价格： ￥ 面议
商品编号： AI-0390-1319
软件语言： 英文
器械分类： II
生产厂家： Quibim
公司网址： https://quibim.com/
认证信息： FDA
系统要求： Windows
交付方式： 下载安装
  • 软件概览
  • 推荐配置
  • 典型病例
  • 软件教程
  • 临床文献
  • 用户评价
  • 产品彩页

软件概览

QP-Prostate®

Your advanced solution for prostate MRI based on Artificial Intelligence for cancer detection and diagnosis.



Discover QP-Prostate®

Prostate cancer is the second most common  cancer in men, representing a significant public health concern. While MRI scans are essential for early detection, the growing demand has surpassed the availability of radiology experts, with diagnostic delays and inconsistencies in interpretation as direct consequences. Only a minority of the medical community consistently follows PI-RADS v2.1 guidelines.


QP-Prostate introduces enhanced diagnostic capabilities, streamlining radiologists’ workflows by automatically ensuring compliance with PI-RADS v2.1 guidelines, accurately segmenting the prostate gland, and efficiently identifying suspicious lesions. These advancements enable radiologists to provide faster and more accurate assessments, directly improving patient care.


1748959264142.png


Aggressive cancer detection and diagnosis

QP-Prostate is setting a new standard for accuracy, speed, and diagnostic precision. Its AI algorithm identifies and stratifies by likelihood intermediate and high-grade aggressive prostate cancer lesions, and provides a segmentation of the prostate. This allows Health Care Professionals to improve their diagnostic accuracy and fusion biopsy planning.



Your AI solution for advanced prostate cancer detection

1. Unmatched clinical evidence

Quibim is setting new benchmarks in diagnostic accuracy and elevating the standard in clinical practice. With a 10% increase in sensitivity, QP-Prostate AI tool increases expert radiologists’ detection rates by up to 90%*.

2. Optimizing specificity

With Quibim’s dual-validation approach using both systematic and targeted biopsies, our algorithms are robustly validated against the most comprehensive ground truth data available in the industry.

3. Fully automated workflow

Our workflow integrates seamlessly into existing systems, providing clinicians a streamlined, efficient diagnostic process that is unpaired in the industry.

4. Regulatory status

Quibim meets international regulatory standards and is a pioneer in securing approvals across global markets. QP-Prostate has received, among others, CE marking, UKCA marking, and 510(k) clearance, setting us apart in the US market.



How does it work?

Efficient workflow, increased confidence.


1748959137112.png







推荐配置


典型病例

Clinical Case 01.

65 yo biopsy patient with PSA: 5,1 ng/ml.


THE RADIOLOGIST DETECTS 3 LESIONS:

- L1 in the right anterolateral region of the medial gland in the transition zone. (PI-RADS 4).-L2 in the right posterolateral region in the peripheral zone. (PI-RADS 3).- L3 in the left posterolateral region of the apex in the peripheral zone. (P-RADS 3)

QP-PROSTATE DETECTS 2 LESIONS:

-L1 Highly suspicious

- L2 No lesion.

-L3 Moderately suspicious.

TARGETED BIOPSYCONFIRMED 2 LESIONS:

-L1 Gleason score 4+3.

-L2 Benign Prostatic Tissue.

-L3 Gleason score 3+4.


1748957969801.png


Clinical Case 02.

74 yo biopsy patient with PSA: 15 ng/ml.


THE RADIOLOGIST DETECTS 1 LESION:

-L1 in the in the middle gland peripheral zone posteromedial/lateral area. (PI-RADS 4).

QP-PROSTATE DETECTS 1 LESION:

- L1 No lesion.

-L2 suspicious lesion.

TARGETED BIOPSYCONFIRMED 1 LESION:

-L1 Benign Prostatic Tissue.


1748957980643.png


Clinical Case 03.

69 yo biopsy patient with PSA: 5 ng/ml.


THE RADIOLOGIST DETECTS 1 LESION:

-L1(PI-RADS3 DCE+, PIRADS 4)

QP-PROSTATE DETECTS O LESION:

-L1 No lesion.

TARGETED BIOPSY CONFIRMED O LESION:

-L1 Benign Prostatic Tissue.


1748958004780.png


软件教程


临床文献

Quibim’s QP-Prostate® CAD, including lesion detection and diagnosis capability, cleared by FDA


1749098666682.png

用户评价


产品彩页

Aggressive cancer detection and diagnosis

QP-Prostate is setting a new standard for accuracy, speed, and diagnostic precision. Its AI algorithm identifies and stratifies by likelihood intermediate and high-grade aggressive prostate cancer lesions, and provides a segmentation of the prostate. This allows Health Care Professionals to improve their diagnostic accuracy and fusion biopsy planning.


1748958171035.png

请完善个人信息

非常抱歉，您只有购买软件后才能查看完整软件教程！

看了此商品的会员还在看
测试版
版本号 软件大小 下载地址
01 1m 下载
正式版
版本号 软件大小 下载地址
01 1m 下载